| Cloverlodge Care Center | |
| 301 North 13th Street, St Edward, Nebraska 68660 | |
| (402) 678-2294 | |
| Name | Cloverlodge Care Center |
|---|---|
| Location | 301 North 13th Street, St Edward, Nebraska |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 47 |
| Occupancy Rate | 56.6% |
| Medicare ID (CCN) | 285201 |
| Legal Business Name | Vsl St Edward Llc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1801905641 |
| Organization Name | HERITAGE OF FAIRBURY-ST EDWARD, INC |
| Doing Business As | CLOVERLODGE CARE CENTER |
| Address | 301 N 13th St, Saint Edward, NE 68660 |
| Phone Number | 402-678-2294 |
News Archive
Virtual Radiologic Corporation, a leading global provider of teleradiology services and technology solutions, has completed the deployment of vRad® PACS, its proprietary picture communications and archiving system for radiologic case processing.
VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.
Identifying gaps in infection prevention practices may yield opportunities for improved patient safety, according to a survey published in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Biomedical engineers at the UConn School of Dental Medicine recently developed a handheld 3D bioprinter that could revolutionize the way musculoskeletal surgical procedures are performed.
A probiotic bacterium, Lactobacillus plantarum 299, has been used to out-compete the dangerous bacteria that cause respiratory illness in ventilated patients.
› Verified 9 days ago
| NPI Number | 1891225447 |
| Organization Name | VSL ST EDWARD LLC |
| Doing Business As | CLOVERLODGE CARE CENTER |
| Address | 301 N 13th St, Saint Edward, NE 68660 |
| Phone Number | 402-678-2294 |
News Archive
Virtual Radiologic Corporation, a leading global provider of teleradiology services and technology solutions, has completed the deployment of vRad® PACS, its proprietary picture communications and archiving system for radiologic case processing.
VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.
Identifying gaps in infection prevention practices may yield opportunities for improved patient safety, according to a survey published in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Biomedical engineers at the UConn School of Dental Medicine recently developed a handheld 3D bioprinter that could revolutionize the way musculoskeletal surgical procedures are performed.
A probiotic bacterium, Lactobacillus plantarum 299, has been used to out-compete the dangerous bacteria that cause respiratory illness in ventilated patients.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Virtual Radiologic Corporation, a leading global provider of teleradiology services and technology solutions, has completed the deployment of vRad® PACS, its proprietary picture communications and archiving system for radiologic case processing.
VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.
Identifying gaps in infection prevention practices may yield opportunities for improved patient safety, according to a survey published in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Biomedical engineers at the UConn School of Dental Medicine recently developed a handheld 3D bioprinter that could revolutionize the way musculoskeletal surgical procedures are performed.
A probiotic bacterium, Lactobacillus plantarum 299, has been used to out-compete the dangerous bacteria that cause respiratory illness in ventilated patients.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.72 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.64 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 36.84 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.55 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.38 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.3 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.3 | 83.88 |